+91 9891296838/9811747774

BLINCYTO (blinatumomab) for injection
Can be imported and made available on "Patient Name basis" treatment in India.

BLINCYTO (blinatumomab) for injection is a prescription medicine. BLINCYTO (blinatumomab) for injection is used to treat acute lymphoblastic leukemia (ALL) and Relapsed or refractory B-cell precursor acute lymphoblastic leukemia. If you have questions, please email IPN Support Team or Call Indian Pharma Network on +91 9891296838 (Mr. Tarun) / 9811747774 (Mr. Neeraj) for price list or cost in India.

BLINCYTO (blinatumomab) for injection is a prescription medicine. BLINCYTO (blinatumomab) for injection is used to treat acute lymphoblastic leukemia (ALL) and Relapsed or refractory B-cell precursor acute lymphoblastic leukemia. BLINCYTO is a bispecific CD19-directed CD3 T-cell engager indicated for the treatment of adults and children with:
• B-cell precursor acute lymphoblastic leukemia (ALL) in first or second complete remission with minimal residual disease (MRD) greater than or equal to 0.1%.
• Relapsed or refractory B-cell precursor acute lymphoblastic leukemia

Source content :

BLINCYTO (blinatumomab) for injection injection suppliers for India and other countries. Indian Pharma Network (IPN) New Delhi, INDIA.

IPN is a facilitator under Patient Assistance Programs. Expertise in Specialty Pharmaceutical distribution having its PAN India presence in Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, lucknow, north East and Pune and other cities in India. with over 20 years of domain experience.

For procurement cost of BLINCYTO (blinatumomab) for injection injection brand in India, sold by indian drug manufacturer. Please call at M: +91 9811747774 (Mr. Tarun) / 9891296838 (Mr. Neeraj) or Email Us to know more details about the BLINCYTO (blinatumomab) for injection injection medicine cost price in India.

The order for BLINCYTO (blinatumomab) for injection injection will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.

Blinatumomab, sold under the brand name Blincyto, is a biopharmaceutical medication used as a second-line treatment for Philadelphia chromosome-negative relapsed or refractory acute lymphoblastic leukemia. It belongs to a class of constructed monoclonal antibodies, bi-specific T-cell engagers (BiTEs), that exert action selectively and direct the human immune system to act against tumor cells. Blinatumomab specifically targets the CD19 antigen present on B cells. In December 2014, it was approved by the US Food and Drug Administration under the accelerated approval program; marketing authorization depended on the outcome of clinical trials that were ongoing at the time of approval.

BLINCYTO (blinatumomab) for injection, for intravenous use.
Initial U.S. Approval: 2014

For injection: 35 mcg of lyophilized powder in a single-dose vial for reconstitution.
Please see the Full Prescribing Information, including Patient Information, for BLINCYTO.
BLINCYTO (blinatumomab) for injection injection
You must agree before submitting.

News / Update for BLINCYTO (blinatumomab) for injection .

For BLINCYTO (blinatumomab) Indications And Usage, Dosage And Administration, Dosage Forms And Strengths and Drug Interactions For More Details

Kymriah, Blincyto and Besponsa to drive acute lymphocytic leukemia market growth For More Details

FDA expands approval of Blincyto for treatment of a type of leukemia in patients who have a certain risk factor for relapse


Steps to access BLINCYTO (blinatumomab) for injection.

Step 1. You send a request for your medicine online:- Submit a request for a specific medicine, or a general request, and your Patient Support Manager will contact you within 24 hours. They will be there to support and guide you in anyway possible to help you get the medicine you need.

Step 2. We verify your prescription and medical details:- Since we help patients access medicines not available in their home country, our first step is to check that the medicine you need is not currently available in your home country. Next we will also verify that you have a prescription from a doctor in your home country for the medicine you need.

Step 3. We source your medicine:- Once we have verified your prescription and medical details, our expert sourcing team will work with our global network of suppliers to find you the best price. Once we have found you the lowest possible cost for your medicine, we will present you with a final offer for your approval.

Step 4. We deliver your medicine:- After you have accepted our offer, our experienced logistics team will arrange all the shipping and transportation of your medicine.

Documentation under Named-Patient import

Doctor’s Prescription –
We would require prescription from registered medical practitioner stating product name, dosage, duration of treatment and diagnosis.

Patient’s Medical history –
We would require all test reports and medical reports of the patient for last 3 months.

Patient’s Identity card –
We will require scan copy of patient’s identity card and proof of residence to initiate documentation process. you can use copy of passport, driving license, employee ID card or any photo id document as your identity card.

BLINCYTO (blinatumomab) for injection exporter and suppliers in India

Can I get anti-cancer medicines even if I am not based in India?
Almost all countries across the world have provisions for granting access to drugs prior to marketing approval for personal use for patients who have exhausted all other treatment options available in their country. Indian Pharma Network, New Delhi can help patients in accessing/importing Ant-cancer medicines, unapproved in their home country against a legitimate prescription and in conformity with all local laws and regulations of their home country.

Send your query to find the best price of -
BLINCYTO (blinatumomab) for injection in South East Asia – China (Beijing, Chongqing, Shanghai, Tianjin and Shenzhen), Cambodia, Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Hong Kong.
BLINCYTO (blinatumomab) for injection in United Arab Emirates – Iraq, Iran, Saudi Arabia, Jordan.
BLINCYTO (blinatumomab) for injection in North America – Mexico.
BLINCYTO (blinatumomab) for injection in South America – Argentina, Brazil, Chile, Colombia, Peru, Venezuela.
BLINCYTO (blinatumomab) for injection in Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia.
BLINCYTO (blinatumomab) for injection in Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia.
BLINCYTO (blinatumomab) for injection in African Countries – Algeria, Mauritius, Uganda, Zimbabwe.
BLINCYTO (blinatumomab) for injection in Australia and New Zealand.

Room temperature shipping

For this medication, standard shipping applies. This means that a consistent room temperature of 15 to 25°C is maintained during transit.

Your order will be shipped to you by our partner couriers, such as DHL, UPS and specialised cold chain couriers. If you would like your order to be shipped by a specific courier, please inform us when you place the order. Our standard delivery time varies from 5 to 10 working days. The shipping cost depends on the medicine and the destination country. After making an enquiry, you will receive a detailed quote that includes the shipping costs.

IPN, New Delhi a trusted pharmaceutical exporter and wholesaler for Anti-Cancer Medicines in India.
Branch Offices in India : New Delhi | Bengaluru | Kolkata | Lucknow | Jaipur | Jodhpur